Search Results

1 - 10 of 89 items :

Clear All

-2006. 5. Żarnowski T, Chmiel M, Haszcz D, Zagórski Z. Evaluation of astigmatism and blood-aqueous barrier breakdown following procedures in the anterior eye segment. Klin Oczna. 1998;100(1):11-4. 6. Szymulska M, Haszcz D, Rakowska E, Zagórski Z. Wartość badań bakteriologicznych w chirurgii zaćmy. Klin Oczna. 1996;98:125-7. 7. Apt L, Isenberg SJ, Yoshimori R, et al. The effect of povidone-iodine solution applied at the conclusion of ophthalmic surgery. Am J Ophthalmol. 1995;119:701-5. 8. Ciulla TA, Starr MB, Masket S. Bacterial endophthalmitis prophylaxis for cataract

. Poczucie jakości życia u pacjentów chorych na zaćmę, [w:] Oleś P, Steuden S, Toczołowski J, red. Jak świata mniej widzę. Zaburzenia widzenia a jakość życia. Lublin: Tow Nauk KUL; 2002. 9. Chan CW, Wong JC, Chan KS, et al. Evaluation of quality of life in patients with cataract in Hong Kong. J Cataract Refract Surg. 2003;29(9): 1753-1760. 10. Jaworska I, Wrońska I. Jakość życia pacjentów z zaćmą. Journal of Education, Health and Sport. 2015, 5(3): 229-246. 11. Kurowska K, Celmer-Ozdowska I. Depresyjność a jakość życia u osób z rozpoznaną zaćmą. Hygeia Public Health 2014

REFERENCES 1. Allen D, Vasavada A. Cataract and surgery for cataract. BMJ 2006; 333 (7559): 128–32. 2. WHO. Visual impairment and blindness Fact Sheet N°282. August 2014. 3. Worgul BV, Merriam GR Jr, Medvedovsky C. Cortical cataract development–an expression of primary damage to the lens epithelium. Lens Eye Toxic Res. 1989;6(4):559-71. Review. 4. Truscott RJ, Friedrich MG. The etiology of human age-related cataract. Proteins don’t last forever. Biochim Biophys Acta. 2016 Jan;1860(1 Pt B):192-8. 5. Mamatha BS, Nidhi B, Padmaprabhu CA, Pallavi P, Vallikannan B

References 1. Vlăduțiu C, Chiseliță D, Voinea L, Tătaru C, Filip M, Baltă F, et al. Cristalinul, Popescu I, Ciuce C: Tratat de chirurgie. Academia Română, București, 2013;111-195 2. Yanoff M, Duker JS. Cataract: Ophthalmology. Mosby, Spain, 2004, 37:280-282/ Lens replacement 40:293-308/ Patient work-up for cataract surgery 43:327-330 3. Masket S, Fram N. Pseudophakic negative dysphotopsia: surgical management and new theory of etiology. J Cataract refract Surg. 2011; 37:1199-1207 4. Jafarinasab MR, Feizi S, Baghi AR, Ziaie M, Yaseri M. Aspheric versus Spherical

vitreous body. Anat Rec (Hoboken) 1988, 220:435-441. 8. Aguirre GD, Rubin LF, Bistner SI: Development of the canine eye. Am J Vet Res 1972, 33:2399-2414. 9. Gemensky-Met zler AJ, Wilkie DA: Surgical management and histologic and immuno histochemical features of a cataract and retrolental plaque secondary to persistent hyperplastic tunica vasculosa lentis/persistent hyperplastic primary vitreous (PHTVL/PHPV) in a Bloodhound puppy. Vet Ophthalmol 2004, 7:369-375. 10. Duddy JA, Po wzaniuk WC, Rubin LF: Hyaloid artery patency in neonatal beagles. Am J Vet Res 1983, 44

principles. Phytother Res   24 : 741-747. Beyer-Mears A, Farnsworth NP. (1979). Diminished sugar cataractogenesis by quercetin. Exp Eye Res   28 : 709-716. Bhimanagouda S, Patil GK, Jayaprakasha KN, Chidambara Murthy, Amit Vikram. (2009). Bioactive Compounds: Historical Perspectives, Opportunities, and Challenges. J Agric Food Chem   5 : 8142-8160. Bischoff SC. (2008). Quercetin: potentials in the prevention and therapy of disease. Curr Opin Clin Nutr Metab Care   11 : 733-740. Bockelbrink A, Roll S, Ruether K, Rasch A, Greiner W, Willich SN. (2008). Cataract surgery

References 1. Hejtmancik JF, Kaiser-Kupfer MI, Piatigorsky J. Molecular biology and inherited disorders of the eye lens. In: CR Scriver, AL Beaudet, D Valle, WS Sly, B Childs, KW Kinzler, B Vogelstein, editors. The metabolic and molecular basis of inherited disease. Vol. 8. McGraw Hill; New York: 2001. 2. Graw J. Genetics of crystallins: cataract and beyond. Exp Eye Res. 2009 Feb;88(2):173-89. PubMed PMID: 19007775. Epub 2008/11/01. 3. Yi J, Yun J, Li ZK, Xu CT, Pan BR. Epidemiology and molecular genetics of congenital cataracts. Int J Ophthalmol. 2011

. Clinical outcomes after cataract surgery with implantation of the Tecnis ZMB00 multifocal intraocular lens. Medical Science Monitor . 2014;15;20:1220-1226. 5. Tester R, Pace NL, Samore M, Olson RJ. Dysphotopsia in phakic and pseudophakic patients: Incidence and relation to commonly used intraocular lenses. Journal of Cataract &Refractive Surgery . 2000;26:810-816. 6. Holladay JT, Lang A, Portney V. Analysis of edge glare phenomena in intraocular lens edge designs. Journal of Cataract &Refractive Surgery . 1999;25:748-752. 7. Davison JA. Positive and negative

References Anderson RS, Shearer TR and Claycomb CK. (1986). Selenite-induced epithelial damage and cortical cataract. Curr Eye Res   5 : 53-61. Anderson RS, Trune DR and Shearer TR. (1988). Histologic changes in selenite cortical cataract. Invest Ophthalmol Vis Sci   29 : 1418-1427. Augusteyn RC. (2007). Growth of the human eye lens. Mol Vis   13 : 252-257. Aydin B, Yagci R, Yilmaz FM, Erdurmus M, Karadağ R, Keskin U, Durmus M and Yigitoglu R. (2009). Prevention of selenite-induced cataractogenesis by N-acetylcysteine in rats. Curr Eye Res   34 : 196

Abstract

Personality correlates in patients with eye diseases have bidirectional influence. It is possible that personality variables lead to behaviours that may influence the cause of eye problems, but the opposite is also possible, that eye problems could have a direct effect on personality.

The aim of this study was to evaluate personality traits in patients with glaucoma, diabetic retinopathy and cataract using the Eysenck Personality Questionnaire.

Obtained results showed similar personality profiles in patients with glaucoma, diabetic retinopathy and cataract. However, extraversion and neuroticism were higher in patients with diabetes, while the psychopathic traits are the highest in the group of cataract.

Age and gender of patients do not influence the scores obtained on the questionnaire confirmed with one way ANOVA. Not significant difference in parameters (tested with Student t-test) was obtained between groups.

It is proposed psychological evaluation to be included in the assessment of more serious eye diseases for helping patients to adjust and adapt to the condition and treatment.